Solvatomorphism and first-time observation of acid-acid catemer in 4-phenylamino-benzoic acids.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
07 Jul 2023
07 Jul 2023
Historique:
received:
18
06
2023
accepted:
30
06
2023
medline:
24
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
To investigate the polymorphism in 4-phenylamino-benzoic acids (4-PABAs) in general, and the effect on the polymorphism of these compounds exerted by substitution in particular, a series of 4-PABAs (1-8) varying in the substitution position and pattern were synthesized, and their polymorphic behavior was investigated for the first time. A relatively comprehensive polymorph screening led to the discovery of two forms, one solvent-free and the other solvate, for compounds 1, 3 and 8, and one form for the other compounds. The crystal structures were determined by single-crystal XRD. All the 4-PABAs in the crystal structures are highly twisted, and all the solvent-free crystals are based on the conventional acid-acid dimer motif, except for 2, which has a rarely observed acid-acid catemer motif. Two of the solvates (1-S and 8-S) have pyridine in the lattice while the other (3-S) has dichloromethane. The observation indicates that neither conformational flexibility or substitution alone nor the combination of both leads to polymorphism in these compounds, which is in dramatic contrast to the polymorphism of fenamic acids. The thermal properties of each system were investigated by differential scanning calorimetry and desolvation of the solvates was studied by thermogravimetric analysis. Hirshfeld surface analysis and molecular dynamics simulation were performed to study the mechanism of polymorphism and the intermolecular interactions contributing to the formation and stability of each crystal form.
Identifiants
pubmed: 37484866
doi: 10.1039/d3ra04102f
pii: d3ra04102f
pmc: PMC10357492
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21021-21035Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts of interest to declare.
Références
Chem Commun (Camb). 2009 Jun 14;(22):3199-201
pubmed: 19587912
J Org Chem. 2006 Apr 14;71(8):3270-3
pubmed: 16599627
Cryst Growth Des. 2008;8(1):136-139
pubmed: 19367341
Curr Med Res Opin. 1977;4(8):535-9
pubmed: 326491
J Am Chem Soc. 2012 Jun 20;134(24):9872-5
pubmed: 22690822
J Chem Phys. 2020 Sep 21;153(11):114502
pubmed: 32962378
Bioorg Med Chem. 2016 Mar 1;24(5):929-37
pubmed: 26810709
J Med Chem. 2012 Mar 8;55(5):2311-23
pubmed: 22263837
J Pharm Sci. 2010 Feb;99(2):794-803
pubmed: 19603503
J Neuroinflammation. 2019 Oct 10;16(1):186
pubmed: 31601232
Bioorg Med Chem Lett. 2009 Feb 1;19(3):654-7
pubmed: 19121939
Scand J Rheumatol Suppl. 1979;(24):5-7
pubmed: 373085
Chem Commun (Camb). 2015 Feb 11;51(12):2245-8
pubmed: 25514992
J Comput Chem. 2002 Dec;23(16):1623-41
pubmed: 12395429
J Nippon Med Sch. 2002 Jun;69(3):224-34
pubmed: 12068313
J Inorg Biochem. 2009 May;103(5):738-44
pubmed: 19237201
J Gen Virol. 1969 Mar;4(2):203-14
pubmed: 4306296
J Pharm Biomed Anal. 2020 Feb 20;180:113058
pubmed: 31881398
Bioorg Med Chem Lett. 2011 Mar 1;21(5):1464-8
pubmed: 21277203
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3113-6
pubmed: 17400450
Curr Med Res Opin. 1977;5(2):189-91
pubmed: 340138
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Drugs. 1986;32 Suppl 4:27-45
pubmed: 3552584
Chem Biol Drug Des. 2015 Aug;86(2):223-31
pubmed: 25430863
J Pharmacol Exp Ther. 1998 Oct;287(1):208-13
pubmed: 9765339